RC
BNTX icon

Renaissance Capital’s BioNTech BNTX Stock Holding History

Renaissance Capital’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-34,334
Closed -$4.63M – 89
2022
Q3 		$4.63M Sell
34,334
-2,142
-6% -$327K 2.97% 9
2022
Q2 		$5.44M Buy
36,476
+11,209
+44% +$1.71M 2.9% 10
2022
Q1 		$4.31M Sell
25,267
-7,562
-23% -$1.27M 1.83% 15
2021
Q4 		$8.46M Sell
32,829
-5,755
-15% -$1.58M 2.17% 16
2021
Q3 		$10.5M Buy
+38,584
New +$12.3M 2.12% 15

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Renaissance Capital's BNTX Position: Q4 2022 in Review

Renaissance Capital sold out of BioNTech (BNTX) in Q4 2022, closing a stake of 34,334 shares — an estimated $4.63M sold.

Renaissance Capital first reported a position in BNTX in Q3 2021 and held it in 5 quarters. The position peaked at $10.5M in Q3 2021. 320 funds tracked by Wall St. Rank hold BNTX as of Q4 2022.

  • Renaissance Capital reported no remaining BioNTech position as of Q4 2022 after selling out during the quarter.
  • Renaissance Capital sold 34,334 BioNTech shares in Q4 2022, an estimated $4.63M.
  • Renaissance Capital first reported a position in BioNTech in Q3 2021 and held it in 5 quarters.
  • Renaissance Capital's BioNTech position peaked at $10.5M in Q3 2021.
  • 320 funds tracked by Wall St. Rank held BioNTech as of Q4 2022.

Based on Renaissance Capital's 13F filing for Q4 2022, filed 6 Jan 2023.